Inventaire - your friends and communities are your best library

Alzheimer's disease

author

Randall J. Bateman

2000 -

published in: Nature Reviews Disease Primers

date of publication: 2015-10-15

Cites articles 171

Date

Title

Authors

2015-05-01

Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis

Alexander Drzezga, Mark A. Mintun, Kristian S Frederiksen, Vincent Camus, Wiesje van der Flier, Adriaan A Lammertsma, Philip Scheltens, Andrew B. Newberg, Frederik Barkhof, Bruce L. Miller, Agneta Nordberg, Gil D Rabinovici, Rik Ossenkoppele, Catherine M Roe, William J. Jagust, John Hodges, Juha O. Rinne, Howard J Rosen, Victor L Villemagne, Christopher C Rowe, Cristian E. Leyton, Pascual Sánchez-Juan, William E. Klunk, Karen M. Rodrigue, David J. Brooks, Sander C J Verfaillie, Bart N M van Berckel, Dirk L Knol, Sofie M Adriaanse, Timo Grimmer, Willemijn J Jansen, Pieter Jelle Visser, Marissa D Zwan, Marie Sarazin, Osama Sabri, Henryk Barthel, Norman Koglin, Rik Vandenberghe, Koen Van Laere, Ann D Cohen, Sabine Hellwig, Adam J Fleisher, David Wolk, Gaël Chételat, Alberto Lleó, Karine Madsen, Duk Lyul Na
2015-05-01

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis

Gunhild Waldemar, Sanna-Kaisa Herukka, Hilkka Soininen, Alexander Drzezga, Mark A. Mintun, Sebastiaan Engelborghs, Kristian S Frederiksen, Gayan Perera, Ramesh Kandimalla, Karen M. Rodrigue, Inês Baldeiras, Peter Johannsen, Julius Popp, Betty M Tijms, Daniel A. Alcolea, Isabel Santana, Marcel Verbeek, Vincent Camus, Barbara Mroczko, Dag Aarsland, Wiesje van der Flier, Giovanni B. Frisoni, Philip Scheltens, Henrik Zetterberg, Harald Hampel, Kaj Blennow, Agneta Nordberg, Steven E. Arnold, Johannes Kornhuber, Andrew B. Newberg, John C. Morris, Charlotte Teunissen, Anne M Fagan, Pieter Jelle Visser, David J. Brooks, Enrica Cavedo, Kewei Chen, Juan Fortea, Yvonne Freund-Levi, Lutz Froelich, William J. Jagust, William E. Klunk, Mony J de Leon, Wolfgang Maier, Niklas Mattsson, Alexandre de Mendonça, Vincent Mok, José Luis Molinuevo, Magda N. Tsolaki, Rik Vandenberghe, Jens Wiltfang, Gil D Rabinovici, Rik Ossenkoppele, Catherine M Roe, Lucilla Parnetti, Aleksandra Klimkowicz-Mrowiec, Frans RJ Verhey, Tormod Fladby, Juha O. Rinne, Victor L Villemagne, Christopher C Rowe, Catarina R. Oliveira, Bart N M van Berckel, Dirk L Knol, Timo Grimmer, Willemijn J Jansen, Marie Sarazin, Osama Sabri, Henryk Barthel, Norman Koglin, Ann D Cohen, Sabine Hellwig, Adam J Fleisher, David Wolk, Karine Madsen, Stephanie De Vos, Olive Melissa Minor Peters, Pauline P Aalten, Alberto Lleó, Inez H G B Ramakers, Lorena Rami, Myriam Alexander, Ina S Almdahl, Gaël Chételat, Tomasz Gabryelewicz, Kiran Dip Gill, Olymbia Gkatzima, Mark Forrest Gordon, Lucrezia Hausner, Helmut Hildebrandt, Adrian Ivanoiu, Elisabeth Kapaki, Viviana Lisetti, Jan Marcusson, Olga Meulenbroek, Hanne M Møllergård, Stefan Van der Mussele, Arto Nordlund, Gerald P Novak, George Paraskevas, Sudesh Prabhakar, Pascual Sánchez-Juan, Luiza Spiru, Linda J C van Waalwijk van Doorn, Åsa K Wallin, Marzena Zboch, Koen Van Laere, Duk Lyul Na
2015-03-12

A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial.

Tiina Laatikainen, Timo Strandberg, Jaana Lindström, Jaakko Tuomilehto, Miia Kivipelto, Hilkka Soininen, Antti Jula, Markku Peltonen, Tiia Ngandu, Satu Ahtiluoto, Jenni Lehtisalo, Esko Levälahti, Alina Solomon, Francesca Mangialasche, Teemu Paajanen, Satu Pajala, Rainer Rauramaa, Anna Stigsdotter Neely
2015-06-01

APOEε2 is associated with milder clinical and pathological Alzheimer disease

Bradley Hyman, Rebecca Betensky, Sarah E Monsell, ALBERTO SERRANO-POZO
2015-03-01

Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density

Rik Vandenberghe, Zuzana Walker, Clive Holmes
2015-02-12

Beta-amyloid imaging with florbetaben
2015-01

Tau imaging: early progress and future directions

Colin L. Masters
2015-04-01

Tracking early decline in cognitive function in older individuals at risk for Alzheimer disease dementia: the Alzheimer's Disease Cooperative Study Cognitive Function Instrument

Steven H Ferris, Paul S. Aisen, Rebecca E. Amariglio
2015-01-01

Quality of life in Alzheimer disease: a comparison of patients' and caregivers' points of view.

Sara Bernini, Chiara Zucchella, Elena Sinforiani, Michelangelo Bartolo
2015-01-01

Awareness of disease is different for cognitive and functional aspects in mild Alzheimer's disease: a one-year observation study.

Daniel C Mograbi, Marcia Cristina Nascimento Dourado
2014-08-01

Potential for primary prevention of Alzheimer's disease: an analysis of population-based data

Sam Norton, Fiona E. Matthews, Carol Brayne, Kristine Yaffe, Deborah E Barnes
2014-06-13

Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis

Nick C. Fox, Randall J. Bateman, Peter R Schofield, Alison Goate, Reisa Sperling, Ralph Martins, Dominantly Inherited Alzheimer Network, John C. Morris, Colin L. Masters, Eric M. Reiman, Paul S. Aisen, Bernardino F. Ghetti, Davis C Ryman, Stephen Salloway, Eric McDade, Adrian Danek, Richard Mayeux, John M Ringman, Jessica B Langbaum, Pierre N Tariot, Francisco Lopera
2014-01-01

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease

William E. Klunk, Steven H Ferris, Nick C. Fox, Kaj Blennow, Reisa Sperling
2014-10-07

APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease

Simon M. Laws, Peter J. Snyder, Ralph Martins, Paul Maruff
2014-06-26

Aβ imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome study

Colin L. Masters
2014-03-01

The A4 study: stopping AD before symptoms begin?

Jason Karlawish, Paul S. Aisen
2014-06-01

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

Florence Pasquier, Bruno Dubois, Sebastiaan Engelborghs, Leonardo C de Souza, Randall J. Bateman, Howard Feldman, José Luis Molinuevo, Giovanni B. Frisoni, Yaakov Stern, Philip Scheltens, Harald Hampel, Kaj Blennow, Sebastian J Crutch, Agneta Nordberg, Steven T Dekosky, Bruno Vellas, Jeffrey L. Cummings, Gil D Rabinovici, Dennis J. Selkoe, Nick C. Fox, Stéphane Epelbaum, Marie-Odile Habert, Lon S Schneider, Christopher C Rowe, D Galasko, Stefano Cappa, Stephen Salloway
2014-10-01

Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography

Oskar Hansson, Henrik Zetterberg, Kaj Blennow, Lennart Minthon, Ulf Andreasson, Sebastian Palmqvist, Rikard Owenius, Douglas Hägerström, David J. Brooks
2014-12-24

Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease

Henrik Zetterberg, Michael W. Weiner, John Q. Trojanowski, Kaj Blennow, Niklas Mattsson, Leslie M. Shaw, William J. Jagust, Philip S Insel
2014-07-19

Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease

Michael Donohue, Henrik Zetterberg, Michael W. Weiner, John Q. Trojanowski, Kaj Blennow, William J. Jagust, Niklas Mattsson, Leslie M. Shaw, Philip S Insel
2014-10-22

CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival

Henrik Zetterberg, Kaj Blennow, Tobias Skillbäck, Katarina Nägga, Dorota Religa, Jonathan Bartlett, Anders Wimo, Maria Eriksdotter, Lars Rosengren, Bengt Winblad, Niklas Mattsson, Lena Kilander, Bahman Farahmand, Jonathan M Schott
2014-09-01

Developments in Tau PET Imaging

Pedro Rosa-Neto
2014-11-23

SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease

Oskar Hansson, Henrik Zetterberg, Kaj Blennow, Lennart Minthon, Gunnar Brinkmalm, Ann Westman-Brinkmalm, Lutz Frölich, Lucrezia Hausner
2014-12-01

Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease.

Gunnar Brinkmalm, Oskar Hansson, Hlin Kvartsberg, Wiesje van der Flier, Philip Scheltens, Henrik Zetterberg, Kaj Blennow, Lennart Minthon, Charlotte Teunissen, Erik Portelius, Martin Ingelsson, Ulf Andreasson, Georg Christian Oeder, Lars Lannfelt
2014-01-01

Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease

Steven Joffe, Bruno Vellas, Karl Kieburtz, Paul S. Aisen, Martin R. Farlow
2014-08-01

The preclinical Alzheimer cognitive composite: measuring amyloid-related decline

Alzheimer's Disease Neuroimaging Initiative, Michael Donohue, Michael W. Weiner, Paul S. Aisen, Reisa Sperling, Rema Raman, Alzheimer’s Disease Cooperative Study
2014-01-03

New applications of disease genetics and pharmacogenetics to drug development

Michael W. Lutz, Nanyin Zhang
2014-11-01

Synergistic effect of β-amyloid and neurodegeneration on cognitive decline in clinically normal individuals

Aaron P. Schultz, Rebecca Betensky, Rebecca E. Amariglio
2014-01-01

Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial

Catherine Woodman, Carolyn L Turvey, Suzanne Craft, Neil Kowall
2014-01-01

Predictors of institutionalization in dementia: a three year longitudinal study

Henry Brodaty
2014-02-06

The independent contributions of cognitive impairment and neuropsychiatric symptoms to everyday function in older adults
2014-12-17

Which variable is the strongest adjusted predictor of quality of life in caregivers of patients with dementia?

Ibrahim Abdollahpour

Article - wd:Q60313667

Welcome to Inventaire

the library of your friends and communities

learn more